CLASS II ONGOING Drug recall · Reported 1 Jul 2026 · FDA Enforcement Report
Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma Private
Annora Pharma Private is recalling Lacosamide Tablets, USP, C V, 100mg, distributed nationwide in the US. The recall was initiated on 4 Jun 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0626-2026
- FDA event ID
- 99200
- Recalling firm
- Annora Pharma Private, Hyderabad, N/A
- Brand
- Lacosamide
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 4 Jun 2026
- FDA classified
- 25 Jun 2026
- Reported
- 1 Jul 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Packaging Defects
- Drug class
- Seizure Medication
Timeline
| 4 Jun 2026 | Recall initiated by company | |
| 25 Jun 2026 | Classified by FDA | +21 days |
| 1 Jul 2026 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Which lots are affected?
Lot: A253999, A254000, Expires: 09/30/2027.
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Annora Pharma Private
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Pitavastatin Tablets, 2 mg recalled by Annora Pharma PrivatePitavastatin Calcium | Annora Pharma Private | Packaging Defects | TN |
Other Lacosamide recalls
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lacosamide Oral Solution, USP, 10 mg/mL recalled by Apotex | Apotex | Packaging Defects | Nationwide |
| Drug | CLASS II | Lacosamide Tablets, 50mg recalled by Glenmark PharmaceuticalsLacosamide | Glenmark Pharmaceuticals Inc., USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Lacosamide Tablets 200mg recalled by Glenmark PharmaceuticalsLacosamide | Glenmark Pharmaceuticals Inc., USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Lacosamide Tablets, 100mg recalled by Glenmark PharmaceuticalsLacosamide | Glenmark Pharmaceuticals Inc., USA | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Lacosamide Tablets 150mg recalled by Glenmark PharmaceuticalsLacosamide | Glenmark Pharmaceuticals Inc., USA | Manufacturing (CGMP) Deviations | Nationwide |